Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.3.1.900
Consolidated Statements of Cash Flows
$ in Thousands
 12 Months Ended
Dec. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Cash Flows From Operating Activities    
Net loss $ (11,356) $ (16,073)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 5,030 2,391
Deferred taxes (1,167) (5,035)
Realignment accrual accretion 139 142
Interest accretion 1,095 139
Provision for bad debt 802 0
Other current assets 979 0
Change in fair value of contingent consideration (7,993) 0
Impairment of discontinued operations   1,906
Stock-based compensation 4,017 2,124
Goodwill impairment 15,666 0
Non-cash loss on debt extinguishment 476 0
Asset impairment 635 2,086
Gain on sale of discontinued operations (21,634) 0
Other changes in assets and liabilities:    
Increase in accounts receivable (5,486) (3,422)
Increase (decrease) in unbilled receivable (181) 0
Decrease in other current assets 2,350 3,678
Decrease in other long-term assets 3,286 193
Increase in accounts payable 1,019 786
Decrease in unearned contract revenue (5,201) (929)
Increase (decrease) in accrued salaries and bonus 895 (4,248)
(Decrease) increase in accrued liabilities (3,389) 1,180
Decrease in long-term liabilities 176 (1,296)
Net cash used in operating activities (19,842) (16,378)
Cash Flows From Investing Activities    
Purchase of property and equipment (353) (2,851)
Acquisition of diagnostic assets 0 (8,500)
Acquisition of RedPath, net of cash acquired 0 (13,359)
Loan to privately held non-controlled entity 0 (655)
Net proceeds from sale of assets 26,751 0
Net cash provided by (used in) investing activities 26,398 (25,365)
Cash Flows From Financing Activities    
Cash received from financing arrangement 0 20,000
Repayment of financing arrangement (20,000) 0
Debt extinguishment costs 1,600 0
Cash paid for debt discount and deferred financing costs 0 (557)
Issuance of common stock 451 0
Cash paid for repurchase of restricted shares (208) (228)
Net cash (used in) provided by financing activities (21,357) 19,215
Net decrease in cash and cash equivalents (14,801) (22,528)
Cash and cash equivalents – beginning 23,111 45,639
Cash and cash equivalents – ending 8,310 23,111
Cash paid for taxes 242 115
Cash paid for interest 3,128 0
Supplemental Cash Flow Information [Abstract]    
Contingent consideration - common stock   1,820
Contingent consideration - deferred payments $ 18,549 26,542
Subordinated note payable   $ 7,509